Diabetes patients who underwent PCI for STEMI had nearly four times the mortality rate of patients who did not have diabetes, according to results from the INFUSE-AMI trial published in Catheterization and Cardiovascular Interventions. Study participants with diabetes had more extensive left anterior descending artery disease, more comorbidities and a 30-day mortality rate of 8.1%, compared with 2.3% among the group without diabetes. The 30-day revascularization rate was 6.4% for diabetes patients compared with 1% for non-diabetes patients.

Related Summaries